Arrestin Pathways as Drug Targets - Progress in Molecular Biology and Translational Science - page 479

58. Grassi G, Seravalle G, Quarti-Trevano F, Dell'oro R. Sympathetic activation in con-
gestive heart failure: evidence, consequences and therapeutic implications. Curr Vasc
Pharmacol . 2009;7:137- 145.
59. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T. Enhanced
morphine analgesia in mice lacking beta-arrestin 2. Science . 1999;286:2495 - 2498.
60. Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine anti-
nociceptive tolerance revealed in beta-arrestin-2 knock-out mice. J Neurosci .

2002;22:10494- 10500.
61. Dewire SM, Yamashita DS, Rominger DH, et al. A G protein-biased ligand at the
m -opioid receptor is potently analgesic with reduced gastrointestinal and respiratory
dysfunction compared with morphine. J Pharmacol Exp Ther . 2013;344:708 - 717.
62. Walters RW, Shukla AK, Kovacs JJ, et al. beta-Arrestin1 mediates nicotinic acid-
induced flushing, but not its antilipolytic effect, in mice. J Clin Invest .

2009;119:1312- 1321.
63. Semple G, Skinner PJ, Gharbaoui T, et al. 3-(1H-tetrazol-5-yl)-1,4,5,6-
tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid recep-
tor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in
mice. J Med Chem . 2008;51:5101 - 5108.
64. Kim J, Zhang L, Peppel K, et al. Beta-arrestins regulate atherosclerosis and neointimal
hyperplasia by controlling smooth muscle cell proliferation and migration. Circ Res .
2008;103:70- 79.
65. Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-
arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest .

2006;116:2208- 2217.
66. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. beta-
Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intra-
cellular targeting of activated ERK1/2. J Cell Biol . 2000;148:1267 - 1281.
67. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. barrestin scaffolding of
the ERK cascade enhances cytosolic ERK activity but inhibits ERK mediated
transcription following angiotensin AT1a receptor stimulation. J Biol Chem . 2002;
277:9429- 9436.
68. Ahn S, Shenoy SK, Wei H, Lefkowitz RJ. Differential kinetic and spatial patterns of
beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
J Biol Chem . 2004;279:35518- 35525.
69. Miura S, Zhang J, Matsuo Y, Saku K, Karnik SS. Activation of extracellular signal-
activated kinase by angiotensin II-induced Gq-independent epidermal growth factor
receptor transactivation. Hypertens Res . 2004;27:65- 77.
70. Kim J, Ahn S, Rajagopal K, Lefkowitz RJ. Independent beta-arrestin2 and Gq/protein
kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular
smooth muscle cells converge on transactivation of the epidermal growth factor recep-
tor. J Biol Chem . 2009;284:11953- 11962.
71. Moussa O, Ashton AW, Fraig M, et al. Novel role of thromboxane receptors beta iso-
form in bladder cancer pathogenesis. Cancer Res . 2008;68:4097- 4104.
72. Parent JL, Labrecque P, Orsini MJ, Benovic JL. Internalization of the TXA2 receptor
and

isoforms. Role of the differentially spliced cooh terminus in agonist-promoted
receptor internalization. J Biol Chem . 1999;274:8941- 8948.
73. Chun KS, Lao HC, Trempus CS, Okada M, Langenbach R. The prostaglandin recep-
tor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation
during mouse skin papilloma development. Carcinogenesis . 2009;30:1620- 1627.
74. DeWire SM, Kim J, Whalen EJ, Ahn S, Chen M, Lefkowitz RJ. Beta-arrestin-mediated
signaling regulates protein synthesis. J Biol Chem . 2008;283:10611- 10620.

b